Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Cailin Deal"'
Autor:
Cailin Deal, Angelene F. Richards, Tracy Yeung, Max J. Maron, Ziqiu Wang, Yen-Ting Lai, Brian R. Fritz, Sunny Himansu, Elisabeth Narayanan, Ding Liu, Rositsa Koleva, Stuart Licht, Chiaowen J. Hsiao, Ivana L. Rajlic, Hillary Koch, Michael Kleyman, Mark E. Pulse, William J. Weiss, Jennifer E. Doering, Samantha K. Lindberg, Nicholas Mantis, Andrea Carfi, Obadiah J. Plante
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::42cf464e45ecec222f7250343520feeb
https://doi.org/10.2139/ssrn.4423986
https://doi.org/10.2139/ssrn.4423986
Publikováno v:
Vaccines, Vol 9, Iss 108, p 108 (2021)
Vaccines
Vaccines
Monoclonal antibodies are the fastest growing therapeutic class in medicine today. They hold great promise for a myriad of indications, including cancer, allergy, autoimmune and infectious diseases. However, the wide accessibility of these therapeuti
Autor:
Alejandro B. Balazs, Cailin Deal
Publikováno v:
Current Opinion in HIV and AIDS. 10:190-197
To discuss recent progress in the use of vectors to produce antibodies in vivo as an alternative form of HIV prophylaxis or therapy. Instead of passive transfer of monoclonal antibody proteins, a transgene encoding an antibody is delivered to cells b
Autor:
Mary Grace I. Galinato, Robert R. Birge, Cailin Deal, Harry A. Frank, Dariusz M. Niedzwiedzki
Publikováno v:
Photosynthesis Research. 94:67-78
Carotenes and xanthophylls are well known to act as electron donors in redox processes. This ability is thought to be associated with the inhibition of oxidative reactions in reaction centers and light-harvesting pigment-protein complexes of photosys
Autor:
Cailin Deal, Alejandro B. Balazs
Publikováno v:
Current opinion in immunology. 35
Purpose of the review In this review, we will discuss the field of engineered humoral immunity with an emphasis on recent work using viral vectors to produce antibodies in vivo . As an alternative to passive transfer of monoclonal antibody protein, a
Autor:
Cailin Deal, Diego A. Espinosa, Jane Xie, Gary Ketner, Fidel Zavala, Kasey A. Karen, Cameron Ward, Carolyn M. Nielsen, Robert J. Adams
Decades of success with live adenovirus vaccines suggest that replication-competent recombinant adenoviruses (rAds) could serve as effective vectors for immunization against other pathogens. To explore the potential of a live rAd vaccine against mala
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a9561798299012f94d904a7e791df2f
https://europepmc.org/articles/PMC4288877/
https://europepmc.org/articles/PMC4288877/
Autor:
Gary Ketner, Fidel Zavala, Diego A. Espinosa, Cailin Deal, David Baltimore, Alejandro B. Balazs
Malaria caused by Plasmodium falciparum kills nearly one million children each year and imposes crippling economic burdens on families and nations worldwide. No licensed vaccine exists, but infection can be prevented by antibodies against the circums
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e8e351ec98204568ea189204339f575
https://europepmc.org/articles/PMC4151717/
https://europepmc.org/articles/PMC4151717/
Publikováno v:
Burns : journal of the International Society for Burn Injuries. 40(6)
More than three-quarters of deaths related to major burns are a consequence of infection, which is frequently ventilator associated pneumonia (VAP). A retrospective study was performed, over a five-year period, of ventilated children with major burns
Publikováno v:
Vaccine. 31(32)
Orally delivered replicating adenovirus (Ad) vaccines have been used for decades to prevent adenovirus serotype 4 and 7 respiratory illness in military recruits, demonstrating exemplary safety and high efficacy. That experience suggests that oral adm
Autor:
Christin M. Hong, Cailin Deal, David Baltimore, Yong Ouyang, Alejandro B. Balazs, Dong Sung An
Publikováno v:
AIDS Research and Human Retroviruses. 30:A16-A17
Recent reports in humanized mice and monkeys have found that broadly neutralizing antibodies (bNAbs) can suppress the replication of laboratory strains of HIV and SHIV while bNAb concentration remains high. Vectored ImmunoProphylaxis (VIP) results in